12 West Capital Management’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,903,190
Closed -$18.1M 20
2024
Q3
$18.1M Hold
1,903,190
1.85% 12
2024
Q2
$16.2M Hold
1,903,190
1.67% 14
2024
Q1
$17.6M Hold
1,903,190
1.59% 16
2023
Q4
$18.5M Hold
1,903,190
1.64% 15
2023
Q3
$17.1M Hold
1,903,190
1.55% 18
2023
Q2
$21.4M Buy
1,903,190
+853,190
+81% +$7.56M 1.83% 17
2023
Q1
$11M Buy
+1,050,000
New +$11.6M 0.95% 19
2022
Q2
Sell
-300,000
Closed -$3.82M 26
2022
Q1
$3.82M Buy
+300,000
New +$4.58M 0.23% 22

Other funds holding ENFN

12 West Capital Management's ENFN Position: Q4 2024 in Review

12 West Capital Management sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 1,903,190 shares — an estimated $18.1M sold.

12 West Capital Management first reported a position in ENFN in Q1 2022 and held it in 8 quarters. The position peaked at $21.4M in Q2 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • 12 West Capital Management reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • 12 West Capital Management sold 1,903,190 Enfusion, Inc. shares in Q4 2024, an estimated $18.1M.
  • 12 West Capital Management first reported a position in Enfusion, Inc. in Q1 2022 and held it in 8 quarters.
  • 12 West Capital Management's Enfusion, Inc. position peaked at $21.4M in Q2 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on 12 West Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.